Market Cap: $125.21B
Market Cap: $125.21B
Open
$785.54
Prev. Close
$1,091.67
High
$785.59
Low
$775.98
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments.
McKesson Corporation trades on the New York Stock Exchange under the ticker MCK, priced in USD.
McKesson Corporation has a market capitalisation of $125.21B, based on its latest share price.
MCK trades at 27.17 times its trailing 12-month earnings.
Over the past 52 weeks MCK has traded between $723.68 and $1,121.50.
Yes. McKesson Corporation's dividend yields 0.32% at the current share price, paying out 9% of its earnings.
Profitable, with a net margin of 1.1% over the last 12 months.
The analyst consensus rating for MCK is Buy. Analysts' average 12-month price target of $994.63 implies 8% downside.
Brian S. Tyler is the CEO of McKesson Corporation, which is headquartered in Irving.
Generated automatically from reported financial data. General information only, not financial advice.

McKesson Corporation (Ticker: MCK) makes a significant investment by establishing a new highly automated regional pharmaceutical distribution center in Moore, Oklahoma. This facility is essential for…

McKesson Corporation (Ticker: MCK) makes a significant leap forward in the U.S. healthcare supply chain with the announcement of a new automated distribution facility in Moore, Oklahoma. This strategi…

McKesson Corporation (Ticker: MCK) is making significant strides in strengthening its financial position through a recent substantial loan agreement and strategic corporate transactions. Strategic Fin…

McKesson (Ticker: MCK) enhances its commitment to innovative healthcare solutions by forming a strategic partnership with Nanoscope Therapeutics focused on a promising retinal gene therapy. This colla…